Position in VCEL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$10,501,251
-$1,598,395 QoQ
Shares Held
326,430
-2.9% QoQ
Ownership
0.639%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 75.21551328002941.ToString("F0")%
Shared 0.ToString("F0")%
None 24.78448671997059.ToString("F0")%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,578,690,346 across 405 Biotechnology names. VCEL ranks #69 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in VCEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,501,251 | 326,430 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $12,099,646 | 336,008 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $8,464,892 | 268,983 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $11,337,573 | 266,453 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $14,098,533 | 315,969 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $31,364,260 | 571,194 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $19,080,943 | 451,620 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $22,005,376 | 479,629 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $27,368,968 | 526,124 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $24,628,941 | 691,630 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $21,140,593 | 630,686 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $25,648,511 | 682,686 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $19,248,989 | 656,514 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $17,352,158 | 658,776 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $15,504,628 | 668,303 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,793,094 | 666,922 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $25,867,448 | 676,804 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $28,433,470 | 723,498 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $36,806,667 | 754,235 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $45,725,084 | 870,954 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $40,497,948 | 729,036 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $14,211,715 | 460,224 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $4,689,164 | 253,058 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,783,208 | 201,390 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $1,380,927 | 150,592 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||